Efectos del tratamiento combinado de fármaco más estimulación cognitiva en la demencia moderada: seguimiento de dos años
Authors:
- Carmen Requena HernándezCHCarmen Requena Hernández
- Fernando Maestú UnturbeFUFernando Maestú Unturbe
- Pablo Campo Martínez-LagePMPablo Campo Martínez-Lage
- Alberto Fernández LucasALAlberto Fernández Lucas
- Pedro Gil GregorioPGPedro Gil Gregorio
- Tomás Ortiz AlonsoTATomás Ortiz Alonso
- 1 January 2007
- journal article
- Published by Elsevier in Revista Española de Geriatría y Gerontología
- Vol. 42 (1) , 3-10
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- La revalidation neuropsychologique dans la maladie d’Alzheimer à un stade précoce : principes, méthodes et perspectivesRevue Neurologique, 2004
- Treatment Strategies in Alzheimer???s Disease with a Focus on Early Pharmacological InterventionsDrugs & Aging, 2004
- Donepezil Versus Vitamin E in Alzheimer's Disease Part 2: Mild Versus Moderate–Severe Alzheimer's DiseaseClinical Neuropharmacology, 2002
- The effects of an orally administered cholinergic agonist on REM sleep in major depressionBiological Psychiatry, 2002
- The Efficacy of Donepezil in Alzheimer's DiseaseJournal of Nippon Medical School, 2002
- A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patientsNeurology, 2001
- A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate ADNeurology, 2001
- Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processesEuropean Archives of Psychiatry and Clinical Neuroscience, 1999
- Cognitive stimulation of patients with dementia: Preliminary resultsInternational Journal of Geriatric Psychiatry, 1994
- Direct Assessment of Activities of Daily Living in Alzheimer's Disease A Controlled StudyJournal of the American Geriatrics Society, 1988